← Open Payments lookup

AMANDA OSWALT: Open Payments

NPI 1710175815 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,801 in 19 payments from 9 companies in 2025. Trend: 2023 $493 · 2024 $319 · 2025 $2,801

Honoraria: $1,625Travel & lodging: $911Food & beverage: $265
CompanyPaymentsAmount
Xeris Pharmaceuticals, Inc.7$2,581
Lilly USA, LLC3$52
Novo Nordisk Inc2$38
Medtronic, Inc.2$35
Dexcom, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$22
Otsuka America Pharmaceutical, Inc.1$19
Amphastar Pharmaceuticals, Inc.1$17
Insulet Corporation1$14

Products named: GVOKE HYPOPEN, MOUNJARO, Rybelsus, Dexcom G6 Transmitter, TRINTELLIX, REXULTI, ABRE, PULSESELECT.

Industry payments across MO — which companies pay providers there.